[go: up one dir, main page]

TWI349549B - Medicament for treatment of intraocular angiopoietic disease - Google Patents

Medicament for treatment of intraocular angiopoietic disease

Info

Publication number
TWI349549B
TWI349549B TW093103856A TW93103856A TWI349549B TW I349549 B TWI349549 B TW I349549B TW 093103856 A TW093103856 A TW 093103856A TW 93103856 A TW93103856 A TW 93103856A TW I349549 B TWI349549 B TW I349549B
Authority
TW
Taiwan
Prior art keywords
intraocular
medicament
treatment
angiopoietic
disease
Prior art date
Application number
TW093103856A
Other languages
English (en)
Other versions
TW200503684A (en
Inventor
Tomihisa Yokoyama
Tatsuya Inoue
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of TW200503684A publication Critical patent/TW200503684A/zh
Application granted granted Critical
Publication of TWI349549B publication Critical patent/TWI349549B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW093103856A 2003-04-15 2004-02-18 Medicament for treatment of intraocular angiopoietic disease TWI349549B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003109918 2003-04-15

Publications (2)

Publication Number Publication Date
TW200503684A TW200503684A (en) 2005-02-01
TWI349549B true TWI349549B (en) 2011-10-01

Family

ID=33295936

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093103856A TWI349549B (en) 2003-04-15 2004-02-18 Medicament for treatment of intraocular angiopoietic disease

Country Status (10)

Country Link
US (1) US20070203211A1 (zh)
EP (2) EP2517728B1 (zh)
JP (2) JP4489020B2 (zh)
KR (1) KR101087519B1 (zh)
CN (1) CN1798576B (zh)
BR (1) BRPI0409293A (zh)
CA (1) CA2522318C (zh)
ES (1) ES2535291T3 (zh)
TW (1) TWI349549B (zh)
WO (1) WO2004091659A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009087900A1 (ja) * 2008-01-11 2009-07-16 Daiichi Sankyo Company, Limited 眼内血管透過性亢進を伴う疾患の予防または治療のための医薬
KR100893652B1 (ko) * 2008-11-10 2009-04-17 주식회사종근당 신규한 텔미사르탄 아연염 및 그의 제조방법
JP5860210B2 (ja) * 2010-12-07 2016-02-16 株式会社オフテクス アンジオテンシンｉｉ受容体拮抗薬であるテルミサルタン及びロサルタンの少なくとも１種を有効成分とする涙液分泌促進用組成物、及びそれを含有する涙液分泌促進用経口投与用製剤
JP6010441B2 (ja) * 2011-12-06 2016-10-19 株式会社ハイマート ノコギリヤシ果実のエタノール抽出物または赤色素を含有する血管新生抑制剤および赤色素の製造方法
CA3031142A1 (en) * 2016-07-20 2018-01-25 P&X Medical Nv Compounds for use in methods for treating glaucoma and retinal diseases
CN119523985A (zh) * 2017-05-27 2025-02-28 青岛海蓝医药有限公司 川芎嗪硝酮衍生物在预防和治疗糖尿病并发症疾病中的应用
US20220257633A1 (en) * 2021-02-17 2022-08-18 The Provost, Fellows, Foundation Scholars, & The O Method of treating age-related macular degeneration

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
IS1756B (is) * 1991-02-21 2000-12-28 Sankyo Company Limited Hliðstæðuaðferð til framleiðslu 1-Biphenylmethylimidazole afleiða
PT573218E (pt) * 1992-06-02 2001-06-29 Sankyo Co 4-carbonilimidazoles como antagonistas de angiotensina ii e sua utilizacao terapeutica
DK0743852T3 (da) * 1994-02-08 2005-10-17 Novartis Ag Behandling af glaukom med normalt tryk med valsartan
AU684916B2 (en) * 1994-03-16 1998-01-08 Sankyo Company Limited Ocular tension depressant
JP4276768B2 (ja) 1999-04-28 2009-06-10 武田薬品工業株式会社 単純網膜症・前増殖網膜症の予防・治療・進展抑制剤
AU774799B2 (en) * 1999-04-28 2004-07-08 Takeda Pharmaceutical Company Limited Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy
AR033390A1 (es) * 2000-08-22 2003-12-17 Novartis Ag Una composicion farmaceutica que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina, el uso de dicha composicion para la fabricacion de un medicamento y un kit de partes
AU2002218527A1 (en) * 2000-12-05 2002-06-18 Sankyo Company Limited Ocular tension-lowering compositions for topical administration
JP4132798B2 (ja) * 2000-12-05 2008-08-13 第一三共株式会社 局所投与のための眼圧低下組成物
US20040121008A1 (en) * 2001-03-16 2004-06-24 Keiko Shiraishi Process for producing sustained release preparation
US20040132731A1 (en) * 2002-06-26 2004-07-08 Fox David Nathan Abraham Novel combination
US20050038093A1 (en) * 2003-05-02 2005-02-17 Boehringer Ingelheim International Gmbh Treating diabetic retinopathy with angiotensin II receptor blockers

Also Published As

Publication number Publication date
JPWO2004091659A1 (ja) 2006-07-06
EP2517728A1 (en) 2012-10-31
EP1614428A1 (en) 2006-01-11
TW200503684A (en) 2005-02-01
BRPI0409293A (pt) 2006-04-11
KR20050120714A (ko) 2005-12-22
KR101087519B1 (ko) 2011-11-28
EP1614428A4 (en) 2010-01-06
CN1798576A (zh) 2006-07-05
CA2522318C (en) 2011-09-13
CN1798576B (zh) 2012-09-26
JP2010143933A (ja) 2010-07-01
US20070203211A1 (en) 2007-08-30
CA2522318A1 (en) 2004-10-28
JP4489020B2 (ja) 2010-06-23
WO2004091659A1 (ja) 2004-10-28
ES2535291T3 (es) 2015-05-08
EP2517728B1 (en) 2015-01-28

Similar Documents

Publication Publication Date Title
HUS1500043I1 (hu) Eljárások Parkinson-kór kezelésére
EG24420A (en) Treatment of ophthalmic conditions
AP2006003671A0 (en) Sulfonamide derivatives for the treatment of diseases
AP2006003669A0 (en) Sulfonamide derivatives for the treatment of diseases
EP1680145A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISEASES
GB0329874D0 (en) Compounds useful for the treatment of diseases
TWI372056B (en) Novel medicament combinations for the treatment of respiratory diseases
GB0320238D0 (en) Treatment of disease
EP1675547A4 (en) GLUCOCEREBROSIDE TREATMENT OF ILLNESSES
EP1500401A4 (en) DRUGS FOR THE TREATMENT OF VASCULAR DISEASES
ZA200605555B (en) Compositions and methods of administering tubulin binding agents for the treatment of ocular disease
TWI349549B (en) Medicament for treatment of intraocular angiopoietic disease
EP1768656A4 (en) TREATMENT OF OCULAR DISEASES
IL174595A0 (en) Glucocerebroside treatment of disease
TWI315984B (en) Agent for treatment of anal disease
GB0428218D0 (en) Medicament for Treatment of Inflammatory Diseases
IL178120A0 (en) Therapeutic combination for treatment of alzheimers disease
GB0327493D0 (en) Treatment medicament
TWI350752B (en) Pharmaceutical composition for the treatment of connective tissue disease
PT1706094T (pt) Tratamento de condições oftalmológicas
HU0302933D0 (en) Treatment of diseases
GB0208194D0 (en) Treatment of disease
AU2003300471A8 (en) Methods for treating ocular diseases
GB0319715D0 (en) Treatment of auto-inflammatory disease
GB0702858D0 (en) Dressinf for tissue treatment

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees